Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
0.2140
-0.0040 (-1.83%)
At close: Nov 13, 2026, 4:00 PM EST
0.2037
-0.0103 (-4.81%)
After-hours: Nov 13, 2026, 7:33 PM EST
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $15.48 million as of November 13, 2026. It is the 38,534th most valuable company in the world and the 5,293rd biggest in the United States. Its market cap has decreased by 86.90% in one year.
Market Cap
15.48M
Enterprise Value
-36.81M
1-Year Change
-86.90%
Global Rank
Country Rank
#5,293 United States
Category
ChartMarket Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $15.48M, a decrease of -97.50%. That is a compound annual growth rate of -49.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 15.48M | -87.89% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 16.28M |
| BioVie | 16.03M |
| Quantum BioPharma | 15.60M |
| NewcelX | 15.54M |
| Tvardi Therapeutics | 15.41M |
| Bolt Biotherapeutics | 15.28M |
| aTyr Pharma | 15.23M |
| Marker Therapeutics | 15.01M |